Evidence map›Paper›PMID 29255284›Full record

ReviewNature microbiology2018

Enterotypes in the landscape of gut microbial community composition.

Paul I Costea, Falk Hildebrand, Manimozhiyan Arumugam, Fredrik Bäckhed, Martin J Blaser, Frederic D Bushman, Willem M de Vos, S Dusko Ehrlich, Claire M Fraser, Masahira Hattori and 19 more

Erratum issuedAbstract readReview
In one paragraph

Review in Nature microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 620 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
620citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

620 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Dissecting the Ecological Structure of Health and Disease in the Global Gut Microbiome.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  19. Article
  20. Article

560 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Paul I CosteaEuropean Molecular Biology Laboratory, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-1645-3947
Falk HildebrandEuropean Molecular Biology Laboratory, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-0078-8948
Manimozhiyan ArumugamThe Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Fredrik BäckhedWallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Martin J BlaserNew York University Langone Medical Center, New York, NY, USA.ORCID http://orcid.org/0000-0003-2447-2443
Frederic D BushmanDepartment of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-4740-4056
Willem M de VosRPU Immunobiology, Department of Bacteriology & Immunology, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0002-0273-3166
S Dusko EhrlichMetagenopolis, Institut National de la Recherche Agronomique, Jouy en Josas, France.
Claire M FraserInstitute for Genome Sciences at the University of Maryland School of Medicine, Baltimore, MD, USA.
Masahira HattoriGraduate School of Advanced Science and Engineering, Waseda University, Tokyo, Japan.
Curtis HuttenhowerDepartment of Biostatistics, Harvard School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0002-1110-0096
Ian B JefferyAPC Microbiome Institute, University College Cork, Cork, Ireland.
Dan KnightsBiotechnology Institute, University of Minnesota, Saint Paul, MN, USA.
James D LewisCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Ruth E LeyMPI Department of Microbiome Science, Tübingen, Germany.
Howard OchmanDepartment of Integrative Biology, University of Texas, Austin, TX, USA.
Paul W O'TooleAPC Microbiome Institute, University College Cork, Cork, Ireland.
Christopher QuinceWarwick Medical School, University of Warwick, Coventry, UK.
David A RelmanDepartment of Microbiology and Immunology, Stanford University, Stanford, CA, USA.
Fergus ShanahanAPC Microbiome Institute, University College Cork, Cork, Ireland.
Shinichi SunagawaEuropean Molecular Biology Laboratory, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-3065-0314
Jun WangWallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
George M WeinstockThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Gary D WuDivision of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Georg ZellerEuropean Molecular Biology Laboratory, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-1429-7485
Liping ZhaoMinistry of Education Key Laboratory for Systems Biomedicine, Shanghai Centre for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Jeroen RaesVIB Center for Microbiology, VIB, Belgium. jeroen.raes@kuleuven.be.
Rob KnightDepartment of Computer Science, University of Colorado, Boulder, CO, USA. robknight@ucsd.edu.ORCID http://orcid.org/0000-0002-0975-9019
Peer BorkEuropean Molecular Biology Laboratory, Heidelberg, Germany. bork@embl.de.

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 1997 to 2026
$32.5M
Elucidating the Evolution of Microbial Genes, Genomes and CommunitiesR35GM118038 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI OCHMAN, HOWARD · 2016 to 2025
$4.0M
Diet, Genetic Factors, and the Gut Microbiome in Crohn's DiseaseUH2DK083981 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI BUSHMAN, FREDERIC D, LEWIS, JAMES D · 2009 to 2010
$2.3M
Biotechnology and Biological Sciences Research Council BB/L027801/1Medical Research Council MR/L015080/1Medical Research Council MR/M50161X/1NIAID NIH HHS P30 AI045008NIDDK NIH HHS P30 DK050306NIDDK NIH HHS UH2 DK083981NIGMS NIH HHS R35 GM118038
6 · The paper itself

Abstract

Population stratification is a useful approach for a better understanding of complex biological problems in human health and wellbeing. The proposal that such stratification applies to the human gut microbiome, in the form of distinct community composition types termed enterotypes, has been met with both excitement and controversy. In view of accumulated data and re-analyses since the original work, we revisit the concept of enterotypes, discuss different methods of dividing up the landscape of possible microbiome configurations, and put these concepts into functional, ecological and medical contexts. As enterotypes are of use in describing the gut microbial community landscape and may become relevant in clinical practice, we aim to reconcile differing views and encourage a balanced application of the concept.

Indexed as

MetagenomeAnimalsBacteriaBacterial Typing TechniquesBiodiversityGastrointestinal MicrobiomeGastrointestinal TractHumansMetagenomicsRNA, Ribosomal, 16SRNA, Ribosomal, 16S

Identifiers

PMID29255284
PMCPMC5832044

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.